Pet dogs spontaneously develop lymphoma. An anthracycline-based multidrug chemotherapy regimen represents the treatment cornerstone; however, cure is rarely achieved. We have been treating dogs with B-cell lymphoma with an autologous vaccine (APAVAC®) and CHOP-based chemotherapy since 2011.
Titolo: | Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers | |
Autore/i: | Marconato, Laura; Aresu, Luca; Stefanello, Damiano; Comazzi, Stefano; Martini, Valeria; Ferrari, Roberta; Riondato, Fulvio; Rouquet, Nicole; Frayssinet, Patrick; Sabattini, Silvia | |
Autore/i Unibo: | ||
Anno: | 2019 | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1186/s40425-019-0624-y | |
Abstract: | Pet dogs spontaneously develop lymphoma. An anthracycline-based multidrug chemotherapy regimen represents the treatment cornerstone; however, cure is rarely achieved. We have been treating dogs with B-cell lymphoma with an autologous vaccine (APAVAC®) and CHOP-based chemotherapy since 2011. | |
Data stato definitivo: | 2019-10-14T21:52:28Z | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.